The Biggest CAR-TCR Meeting Just Got BIGGER
The hotly anticipated 7th Annual CAR-TCR Summit is back, bigger and better than ever, uniting experts with one common goal: engineering a disease-free world.
After the explosive news that CAR-T therapies can now be considered curative, now is the time to unite with your industry, from the long-standing commercial giants to the trailblazing pioneers, and discover new strategies for everything from discovery to early phase development to commercialization.
Gain end-to-end insights from both established thought leaders and the innovators bringing disruptive technologies from bench to bedside and from vein to vein.
Across 3 conference days with 8 tracks, 15 Workshops, 1 Bootcamp and 1 Focus Day, 200+ CAR and TCR experts will lead you and 1,000 of your peers in discussions that will accelerate your pipeline and bring much-needed treatments to patients faster.
You can’t afford to miss the 7th CAR-TCR Summit as we bring you more speakers, more content and more exclusive insights than ever before!
View the Full Event Guide Now!
Download your copy to see all the 2022 speakers, full agenda breakdown, partners and how you can access the best possible rates.
200+ Expert Speakers Including:
Chief Scientific Officer & Executive Vice President, Research & Development
Barbara & Edward Netter Professor in Cancer Gene Therapy
University of Pennsylvania
Chief Executive Officer
Co-Founder, Chief Executive Officer
What’s New for 2022?
Join new companies that have NEVER spoken before such as Currus Biologics, ImmTune Therapies, Rootpath, Strand Therapeutics, Deverra Therapeutics and more as they share new cutting-edge platforms and technologies.
3 Main Conference Days
As the cell therapy space continues to explode with new companies popping up and clinical collaborations driving the field forward, we are keeping up with this growth by bringing you even more content including a new third conference day!
A very popular new addition to the program – the brand new track dedicated to CMC and analytical innovations that are paving the way for greater understanding and characterization of cell products to best showcase quality, safety and potency.
Gathering expert venture capitalists, business angels and corporate venture funds, gain insights into the current priorities of investors, what excites them and how to set your company apart to raise financing and secure reliable streams of capital.
3 Passes - 10% Discount
5 Passes - 15% Discount
8+ Passes - 20% Discount